RPL7AP71

Across TCGA pan-cancer cohorts, RPL7AP71 RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated RPL7AP71 data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher RPL7AP71 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RPL7AP71 expression acts as an unfavorable survival marker, although some lineages such as UCEC and LGG show a favorable association.

LIHC, PAAD, and ACC are the cancer types where RPL7AP71 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	DFS	Tertile	All	0.417	0.576	<.001	48	view →
PAAD	OS	Tertile	II,III,IV	0.442	0.623	.017	39	view →
ACC	DFS	Tertile	All	0.089	0.576	.001	20	view →
CHOL	DFS	Median	All	0.113	0.575	.001	18	view →
UCEC	OS	Tertile	IV	0.837	0.385	.042	12	view →
DLBC	DFS	Median	IV	0.195	0.923	.038	7	view →
LGG	DFS	Median	All	0.838	0.683	.004	7	view →
MESO	OS	Quartile	All	0.450	0.883	.026	6	view →
SKCM	OS	Tertile	II,III,IV	0.202	0.372	.034	2	view →
THYM	DFS	Quartile	II,III,IV	1.000	0.670	.034	2	view →
LUSC	DFS	Quartile	II,III,IV	0.591	0.347	.029	1	view →
THCA	DFS	Quartile	III,IV	0.505	0.781	.027	1	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

RPL7AP71–LIHC (DFS)

Open the LIHC breakdown →